Aperio Group, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,710,000
+2.6%
30,251
-13.9%
0.01%
-16.7%
Q3 2020$1,667,000
-9.6%
35,137
+12.4%
0.01%
-14.3%
Q2 2020$1,844,000
+41.7%
31,271
+13.6%
0.01%
+16.7%
Q1 2020$1,301,000
+7.3%
27,530
+37.1%
0.01%
+50.0%
Q4 2019$1,213,000
-10.1%
20,076
-10.9%
0.00%
-20.0%
Q3 2019$1,350,000
-4.2%
22,535
+2.8%
0.01%
-16.7%
Q2 2019$1,409,000
-6.9%
21,923
+17.6%
0.01%
-14.3%
Q1 2019$1,514,000
+77.5%
18,644
+18.1%
0.01%
+75.0%
Q4 2018$853,000
+2.0%
15,780
-2.6%
0.00%0.0%
Q3 2018$836,000
+33.8%
16,204
+8.0%
0.00%
+33.3%
Q2 2018$625,000
-21.1%
15,001
-16.6%
0.00%
-25.0%
Q1 2018$792,000
-9.9%
17,977
+2.9%
0.00%0.0%
Q4 2017$879,000
-3.6%
17,469
-2.9%
0.00%
-20.0%
Q3 2017$912,000
+1.6%
17,997
+1.9%
0.01%0.0%
Q2 2017$898,000
+30.7%
17,656
+3.4%
0.01%0.0%
Q1 2017$687,000
-23.0%
17,082
-8.4%
0.01%
-28.6%
Q4 2016$892,000
+107.0%
18,642
+58.4%
0.01%
+133.3%
Q3 2016$431,000
+79.6%
11,766
+14.4%
0.00%
+50.0%
Q2 2016$240,000
-18.9%
10,287
+40.8%
0.00%
-33.3%
Q1 2016$296,000
-71.6%
7,305
-56.6%
0.00%
-70.0%
Q4 2015$1,042,00016,8210.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders